Najat Khan, CEO and President at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 56,596 shares at $3.35 ($189K) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Open-market sale of $189k RXRX by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.35 | 28,298 | $95K | 50.0% |
| 2 | $3.35 | 28,298 | $95K | 50.0% |
| Total | $3.35 avg | 56,596 | $189K | 100% |
| Filing → |
| RXRX | SELL | 2025-12-29 | $1.1M | — | Filing → |
| RXRX | SELL | 2025-08-19 | $404K | — | Filing → |